ANDA Application in 2026: FDA Requirements, Submission Process and GMP Inspection Readiness
October 11, 2026
Preparing an ANDA requires more than a complete dossier. This article explains FDA submission requirements, bioequivalence expectations, CMC consistency, facility readiness, and common review delays, helping regulatory and quality teams understand what can slow generic drug approval.